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Abstract
The main function of the corpus luteum (CL) is the production of progesterone. Adequate luteal
progesterone is crucial for determining the physiological duration of the estrous cycle and for
achieving a successful pregnancy. The CL is regulated not only by hypophyseal gonadotropin, but
also by a number of cytokines that are locally produced. Tumor necrosis factor-α (TNF) and its
specific receptors (TNFR) are present in the CL of many species. TNF plays multiple and likely
important roles in CL function throughout the estrous cycle. TNF appears to have luteotropic and
luteolytic roles in the CLs. In contrast, Fas ligand (Fas L), another member of TNF super family
(TNF-SF), is primarily recognized for its apoptotic actions. Presumably, Fas L binds its cognate
receptor (Fas) to induce structural luteolysis. This review is designed to focus on recent studies
documenting the expression of TNF and Fas L, their receptors, and intracellular signaling
mechanisms in the CL.
Introduction
The corpus luteum (CL) is a transient ovarian organ estab-
lished by cells of the follicle following ovulation. The pri-
mary product of the CL, progesterone, is required for the
establishment and maintenance of pregnancy [1]. The
mammalian CL is composed of a heterogeneous mixture
of cell types that consists of not only steroidogenic luteal
cells but also non-steroidogenic cells, i.e., vascular
endothelial cells, fibroblasts, and immune cells such as
lymphocytes and macrophages [2,3]. There is increasing
evidence that a number of factors locally produced by the
non-steroidogenic cells modulate the CL function.
The function of CL varies from day to day after ovulation.
When animals do not become pregnant, regression of the
CL is essential for normal cyclicity as it allows the devel-
opment of a new ovulatory follicle. Functional regression
of CL, characterized by inhibition of progesterone produc-
tion, is followed by structural regression. During luteoly-
sis, cells of the CL undergo apoptosis, a process that has
been described by morphological and biochemical
parameters in many domestic species including the cow
[4,5], pig [6] and sheep [7].
It is generally accepted that the immune system plays a
central role in apoptosis of several tissues and cell types
[8]. Furthermore, since the number of leukocytes in
bovine CL (e.g., T lymphocytes, macrophages) increase at
the time of luteolysis [9], it is assumed that leukocytes
mediate apoptosis during CL regression. Leukocytes are
known to produce a variety of cytokines, including tumor
necrosis factor-α (TNF) and interferon-γ (IFN), which
have been shown to affect luteal cell function in vitro [10].
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TNF, a non-glycosylated protein with a molecular weight
of 17 kDa, was first described as a tumoricidal factor pro-
duced by activated macrophages [11]. This protein pos-
sesses a wide repertoire of biological actions that include
not only the regulation of proinflammatory responses but
also the control of cell differentiation, tissue renewal and
restructuring [12]. Extensive research during the last dec-
ade suggests that TNF physiologically plays multiple roles
in ovarian function in a variety of species [13–15]. Fur-
thermore, the release of TNF is associated with the expres-
sion of TNF alpha converting enzyme (TACE) in cells [16]
and intracellular concentrations of TACE may be crucial
for modulating TNF production and subsequent local
actions. TNF belongs to TNF super family (TNF-SF), which
consists of 18 members. The TNF-SF members have a con-
served C-terminal domain coined the TNF homology
domain. This trimeric domain, which is responsible for
receptor binding, has 20–30% sequence identity between
family members. The receptors for the TNF-SF ligands also
constitute a TNF receptor super family (TNFR-SF). The
disulfide bonds from "cysteine-rich domains" that are the
hallmark of the TNFR-SF. The familiar as well as standard-
ized names of these proteins together with their gene loca-
tions are listed in following address http://
www.gene.ucl.ac.uk/nomenclature/genefamily/
tnftop.html. Fas ligand (Fas L), another member of the
TNF-SF primarily engages its membrane receptor (Fas) to
induce apoptosis [17]. Fas L is expressed at high levels on
activated T lymphocytes [18] and mediates apoptosis of
target cells [17]. Recent studies suggest that Fas-mediated
apoptosis plays an important role in structural regression
of the CL in a variety of species [19–22]. It is also possible
that Fas L works in conjunction with other cytokines (TNF
and IFN) to regulate luteal regression [22,23]. This review
will focus on studies documenting roles of TNF-SF mem-
bers in the CL, with emphasis on TNF and its receptors
and Fas L and its receptors in the structural CL regression,
i.e., apoptosis following the functional CL regression. Fur-
thermore, possible roles of TNF in the CL throughout the
estrous cycle and in the gestation period will be discussed.
TNF and Fas L in luteal formation and 
development
Immunoreactive or bioactive TNF is present in follicles
during follicular development in a variety of animals
[24,25,32–34,38]. Likewise, the TNF receptor (TNFR) is
also present on granulosa and theca cells [39,42,45]. For
more detailed information on the expression of TNF and
TNFR in the ovaries of several species, and the methods
used for detecting TNF and TNFR see Table 1. From a func-
tional standpoint, TNF has been shown to inhibit FSH-,
insulin- or insulin-like growth factor-I (IGF)-induced
estradiol-17β (estradiol) production in granulosa cells
[52,53] and LH-stimulated androstenedione production
in theca cells [53]. These observations led to the idea that
TNF plays one or more physiological roles in regulating
follicular cell function. One possible role of TNF in the
follicles is to mediate the mechanism of ovulation. In
cows, maximum levels of bioactive TNF are observed in
the dominant follicles [24]. In addition, intrafollicular
injection of TNF antibodies after administration of GnRH
blocked ovulation in sheep [36]. Other studies focusing
on the role of TNF in ovulation have been conducted in
rats [54] and sheep [55].
Although TNF exerts pleiotropic responses in various tar-
gets tissues, the engagement of Fas with Fas L is primarily
known for its role in apoptosis in various cell types. As
shown in Table 2, Fas and Fas L are expressed in ovarian
granulosa or theca cells in multiple species [46–48,51].
Activation of Fas/Fas L system is thought as a key event in
follicular atresia [56]. Although it is a very interesting
topic, we will limit our detailed review to the Fas/Fas L sys-
tem in the process of follicular development in the ovary.
Table 1: Ovarian TNF and TNF receptors (TNFR) in various animals1)
Species Sources Stages of the estrous cycle2) Method of detection Ref.
FII II I IR P
TNF
Cow Follicular fluid + Bioactivity [24]
Theca cells + IHC [25]
Corpus luteum + + MDS/RIA [26]
Corpus luteum + + + + + RT-PCR/ELISA [27]
Corpus luteum + RT-PCR [28]
Pig Corpus luteum + + + + + RT-PCR [29]
Macrophages/CL + + + IHC [30]
EC/CL + + + IHC/Western blot [31]
Human Follicular fluid + ELISA [32]
Granulosa cells + IHC [33]
Theca cells + In situ hybridization [34]
Corpus luteum + + + + IHC [35]Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/95
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TNF and TNFR are evident in the early stage CL in cows
[27], pigs [29,44], and human [35] (Table 1). TNF is a
potent stimulator of luteal prostaglandins (PGs) includ-
ing PGF2α, PGE2 and PGI2 [15,27,57]. Luteal PGs are
known to stimulate progesterone production from bovine
CL  in vitro, suggesting that they are luteotropic agents
[58,59]. Macrophages [11,30] and endothelial cells [31]
are sources of TNF, and these cells infiltrate into newly
formed CL concomitant with vascular angiogenesis [60].
Thus, it could be assumed that TNF contributes to the pro-
duction of PGs by early CL, and may partly promote the
formation of CL. Additional studies in human luteinized
granulosa cells support a luteotropic role of TNF [61]. This
effect is not limited to steroidogenic cells since TNF is
capable of stimulating PGE2 secretion by the bovine
luteal endothelial cells [40]. Since both TNF [62] and
PGE2 [63] are known to affect the proliferation of
endothelial cells derived from other tissues, TNF and TNF-
induced PGE2 may be autocrine and/or paracrine regula-
tors of vascular angiogenesis. Taken together, these find-
ings suggest that TNF has a role in stimulating the early
phase of luteal development.
Sheep EC/TC + IF-microscopy [36]
Corpus luteum + Bioactivity [37]
Rat3) Granulosa cells + IHC [25]
Mouse3) GC/TC/CL + + + IHC [38]
TNFR (RI or RII)
Cow GC/TC + RRA/cells [39]
Corpus luteum (RI) + + + + RT-PCR/RRA [27]
Corpus luteum + RRA [28]
EC/CL + RRA/cells [40]
EC/LLC/SLC (RI) + + + + RT-PCR [41]
Pig Granulosa cells + IHC [42]
LLC/SLC + RRA/cells [43]
Corpus luteum + + + + + RRA [44]
Rat3) Ovarian cells (RI, RII) + RT-PCR/RRA [45]
1)Abbreviations; TC: theca cells, GC: granulose cells, EC: endothelial cells, LLC: large luteal cells, SLC: small luteal cells, IHC: immunohistochemistry, 
RRA: radioreceptor assay. 2)Each stage of the estrous cycle was classified as follows; follicular (F), early-CL (I), mid-CL (II), late-CL (III), regressing 
CL (R), and pregnancy (P). 3)Each stage of the estrous cycle was classified as follows; estrus (I), metestrus (II), diestrus (III), proestrus (R), and 
pregnancy or pseudopregnancy (P).
Table 2: Ovarian Fas and Fas ligand (Fas L) in various animals1)
Species Sources Stages of the estrous cycle2) Method of detection Ref.
F I II III R P
Fas
Cow GC/TC + RT-PCR [46]
Corpus luteum + + + + RT-PCR [22]
Human Follicular fluid + ELISA [47]
Corpus luteum + + + + IHC [21]
Rat3) Granulosa cells + TUNEL/IHC [48]
CL/LLC + RT-PCR [49]
Mouse3) Corpus luteum + RT-PCR [50]
Fas L
Cow GC/TC + RT-PCR [51]
Rat3) Granulosa cells + TUNEL/IHC [48]
CL/SLC + RT-PCR [49]
1)Abbreviations; TC: theca cells, GC: granulose cells, EC: endothelial cells, LLC: large luteal cells, SLC: small luteal cells, IHC: 
immunohistochemistry, RRA: radioreceptor assay. 2)Each stage of the estrous cycle was classified as follows; follicular (F), early-CL (I), mid-CL (II), 
late-CL (III), regressing CL (R), and pregnancy (P). 3)Each stage of the estrous cycle was classified as follows; estrus (I), metestrus (II), diestrus (III), 
proestrus (R), and pregnancy or pseudopregnancy (P).
Table 1: Ovarian TNF and TNF receptors (TNFR) in various animals1) (Continued)Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/95
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Fas is expressed in human [21] and bovine [22] CL
throughout the luteal phase. Its presence throughout the
luteal phase could suggest multiple roles including luteal
development, maintenance, and regression. However, the
physiological significance of Fas or its ligand in the devel-
oping CL, if any, is not yet known. Bovine luteal cells
express Fas mRNA and Fas L can induce luteal cell death
[22,64]. Similar results have been shown in bovine gran-
ulosa cells cultured in a medium containing fetal bovine
serum [65]. Quirk et al. [66] demonstrated that bovine
granulosa cells become sensitive to Fas-mediated apopto-
sis when the cells are cultured in serum-free media. How-
ever, Fas mRNA expression in bovine granulosa cells was
not different in the two culture systems (with and without
serum).
Growth factors, such as IGF, block Fas-mediated cell death
in a serum-free medium [66]. IGF is produced locally
within the bovine CL [67] and is a potent luteotropic fac-
tor in bovine luteal cells [68]. In addition, luteal concen-
trations of mRNA encoding IGF and the receptor for IGF
increase during luteal development [69]. Thus, the ability
of Fas L to induce apoptosis in luteal cells is reduced under
conditions in which the cells are regulated by survival fac-
tors such as IGF. Furthermore, Fas mRNA expression in
cultured rat luteal cells has been clearly suppressed by
treatment with progesterone [70]. These data support the
idea that progesterone and IGF act as important factors
that can change the sensitivity of CL to Fas/Fas L system.
It is interesting to note that progesterone suppresses apop-
totic cell death in rat and bovine luteal cells [70,71]. The
suppressive effects of progesterone on Fas-mediated luteal
cell death were not directly related to the amount of Fas
expression in cows [72], but were related in the mouse
model [70]. Furthermore, treatment with a progesterone
antagonist (onapristone) in cultured luteal cells resulted
in reduced cell viability without the presence of Fas L [72].
Therefore, it remains to be clarified how progesterone
controls the apoptotic cell death in the CL (e.g., the stage-
dependent changes of progesterone receptors, and the
effects of progesterone on the intracellular signaling cas-
cade for apoptosis in the CL).
TNF and Fas L in luteolysis
Functional luteolysis
TNF has an inhibitory effect on gonadotropin-stimulated
steroid production in the steroidogenic luteal cells in rats
[13], pigs [14], and cows [15]. Furthermore, LH receptor
and steroidogenic acute regulatory protein mRNA are
reduced by TNF in rat CL [73]. Secretion of TNF in bovine
CL is higher in the late stage CL than in mid luteal phase
CL [26,27]. In addition, specific binding sites for TNF are
present in the bovine CL throughout the luteal phase of
estrous cycle [27]. These studies suggest that TNF affects
CL function as a luteolytic agent. However, how TNF
switches from a luteotropic agent to a luteolytic agent in
the estrous cycle is unknown. Recent investigations about
the synergistic or co-operative actions between TNF and
other substances may clarify these points.
It is well recognized that uterine derived PGF2α is the pri-
mary initiator of luteolysis in many species, especially in
ruminants. PGF2α decreases progesterone production by
cultured luteal cells stimulated by gonadotropins in pigs
[10] and cows [14]. PGF2α also increases endothelin-1
(ET-1) production from endothelial cells in the CL, and it
is presumed that elevated ET-1 augments PGF2α induced
inhibition of progesterone synthesis [41]. Specific bind-
ing sites for TNF are present in endothelial cells derived
from bovine CL [40,41] and ET-1 secretion by the cells is
significantly stimulated by treatment with TNF [40]. Since
it has been shown that high concentrations of ET-1
decreased progesterone production by bovine luteal cells
[74], TNF-induced ET-1 secretion from the endothelial
cells may act on luteal cells as an antisteroidogenic agent
in the CL concomitant with endometrial PGF2α in cattle.
Moreover, PGF2α-induced steroid reduction results in an
activation of inflammatory cells followed by TNF and IFN
secretion in the CL of cows [9], pigs [75], and rabbits [76].
TNF in combination with IFN reduces progesterone pro-
duction and the number of viable cells, although TNF
alone shows little effect, if any [15,77]. Although to date
there is no known study demonstrating IFN is present in
the CL at the protein level, IFN mRNA has been detected
in bovine luteal tissue collected at the end of the luteal
phase of a naturally regressing CL and after induced lute-
olysis [9]. Treatment with IFN by itself can decrease pro-
gesterone levels and induce apoptosis [77]. Realistically,
however, it is likely that TNF works in conjunction with
IFN or other substances (e.g., ET-1 etc.) to inhibit proges-
terone synthesis (i.e., functional regression).
In contrast to ruminants, the CL of pigs, rodents or pri-
mates are known to secrete estradiol as well as progester-
one. Intraluteal estradiol is a potent luteotropic factor,
namely it stimulates progesterone secretion in the CL of
pigs [78]. It has been demonstrated that PGF2α inhibited
progesterone secretion by porcine luteal cells in vitro,
whereas estradiol was stimulated [14]. Moreover, when
the CL is pretreated with TNF, PGF2α reduces progester-
one production more markedly than that in treatment
with PGF2α alone [78]. Since TNF inhibits estradiol pro-
duction of cultured luteal cells [29], TNF may reduce pro-
gesterone levels not only by a direct inhibition of
progesterone secretion but also by inhibiting luteotropic-
estradiol production in the CL of pigs. However, in
human, it has been shown that estradiol is not luteotropic
agent [79]. Thus, the mechanisms of TNF-mediated inhi-Reproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/95
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bition of progesterone secretion seem to be different
among species.
Structural luteal regression
Structural regression of the CL must occur to allow new
follicular development. The importance of interactions
between Fas/Fas L system and other cytokines (i.e., TNF,
IFN) in structural luteolysis has been demonstrated.
Bovine luteal cells became sensitive to Fas L-induced cell
death in the presence of IFN and IFN in combination with
TNF [22]. IFN and TNF have been shown to stimulate Fas
mRNA expression in a variety of ovarian cell types
[22,50,65]. Moreover, the increased sensitivity to Fas L in
bovine luteal cells was correlated with an increase of Fas
mRNA expression induced by cytokines, suggesting that
Fas L induces cell death of bovine luteal cells mediated via
the Fas/Fas L system [22]. Furthermore, the expression of
Fas L protein is elevated in the regressing postpartum rat
CL [20]. Injections of an anti-Fas antigen antibody given
to mice in the pro-estrous period made the CL disappear
[19], suggesting that the Fas/Fas L system mediates apop-
tosis of CL cells in structural regression of the CL. In addi-
tion, administration of a Fas activating antibody to mice
following a gonadotropin induced luteal phase resulted in
increasing apoptosis [80].
As mentioned previously, the number of leukocytes
increases at the time of luteolysis in the CL [9,75,76]. T-
lymphocytes are known to abundantly express Fas L and
to be a primary source of IFN, whereas macrophages are
the main source of TNF [11,18]. Therefore, Fas L expressed
on T-lymphocytes may transduce apoptotic signals to
luteal cells in which Fas expression is induced by leuko-
cyte-derived cytokines. Collectively, these reports suggest
that the Fas/Fas L system may be involved in the physio-
logical process of structural luteolysis in the CL. Interac-
tions between TNF and IFN are also considered important
in the structural regression of the CL. A decrease in proges-
terone levels and interruption of growth factor signaling
in the CL may promote activation of inflammatory cells
resulting in increased TNF and IFN production [75,76].
TNF induces a significant increase in the expression of
major histocompatibility (MHC) class I glycoproteins in
cultured bovine luteal cells [15]. It is hypothesized that
these glycoproteins are recognized by cytotoxic T lym-
phocytes in order for the T lymphocytes to phagocytize
luteal cells [15]. IFN also increases the expression of class
II MHC [81]. In addition, IFN alone reduces the viability
of bovine and murine luteal cells, and that TNF augments
this effect [15,22,78]. Since IFN up-regulates TNFR in a
variety of cell types [82], the luteal cells might become
more sensitive to the action of TNF in the presence of IFN.
These findings support the idea that TNF and IFN also
play important roles in luteolysis, especially at time of
structural regression by a mechanism not mediated via the
Fas/Fas L system.
Intracellular signaling pathways of TNFR and Fas
Possible actions of TNF and Fas L in the luteal cells are
summarized in Figure 1. Two immunologically distinct
TNFR of approximately 55 kDa (Type I; TNFRI) and 75
kDa (Type II; TNFRII) have now been identified [83].
TNFRI and TNFRII have different intracellular signaling
pathways [84]. TNFRI contains an intracellular death
domain, which is required for signaling pathways associ-
ated with apoptosis. In contrast, TNFRII can induce gene
transcription for cell survival, growth, and differentiation.
Our previous work demonstrated that TNFRI mRNA and
the specific binding sites for TNF are present in bovine CL
throughout the estrous cycle, and suggested that at least
one of the receptors for TNF in bovine CL is the TNFRI
[27]. The TNF/TNFRI complex activates phospholipase
(PL)-A2 pathway [85], PL-C or protein kinase (PK)-C
pathway [86], and PK-A pathway [87] in a variety of tis-
sues. TNF stimulates PG secretion by cultured bovine
luteal cells via its specific receptors [15,27]. A selective
inhibitor of PL-A2 completely stopped the actions of TNF,
whereas inhibitors of PL-C, PK-A and PK-C did not signif-
icantly inhibit TNF-induced PGF2α production [88,89].
These results suggest that TNF induces PL-A2 to produce
PGF2α in the bovine steroidogenic luteal cells. In addi-
tion, a selective mitogen-activated protein kinase (MAPK)
inhibitor was recently shown to suppress TNF-induced
PGF2α secretion by cultured bovine luteal cells [88]. Since
MAPK partly regulates cytoplasmic PL-A2 activation in a
variety of cells [90], the MAPK cascade may couple with
the PL-A2 pathway in bovine luteal cells. These findings
suggest that TNF activates the MAPK kinase/MAPK signal-
ing cascade and subsequently activates the PL-A2 pathway
in bovine luteal cells to produce arachidonic acid and PG.
Alternatively, TNF is known to activate cell survival path-
ways, involving activation of nuclear factor-κB (NFκB)
[91]. NFκB has been shown to control transcription of
cyclooxygenase (COX)-2 gene [92]. COX-2 is an inducible
key rate-limiting enzyme for converting arachidonic acid
to PG family [93]. Therefore, TNF-induced PG production
may be also regulated by activation of NFκB and subse-
quent promotion of COX-2 expression.
More recently, it has been shown that TNF-induced sign-
aling in steroidogenic luteal cells resulted in an increase in
phosphorylated p38MAPK and jun-n-terminal kinase (JNK)
[94]. Elevations in JNK activity have been shown to
induce phosphorylation and inactivation of Bcl-2 protein
in the KYM-1 cell lines [95]. Generally, one of the effects
of Bcl-2 is known to suppress apoptotic cell death, and
intracellular levels of Bcl-2 are reduced by stimulation of
TNF in human granulosa cells [96]. These observations
suggest that TNF may augment Fas L or IFN to induceReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/95
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Possible actions of TNF and Fas L in the luteal cells Figure 1
Possible actions of TNF and Fas L in the luteal cells. TNF and Fas show multiple actions on luteal cell function through 
complex intracellular pathways. Fig. 1A shows the possible luteolytic actions of TNF and Fas L in the luteal cells. Fig. 1B shows 
the possible luteotropic actions of TNF in the luteal cells. * Abbreviations; tumor necrosis factor-α (TNF), TNF receptor type 
I (TNFRI), TNF receptor type II (TNFRII), Fas antigen (Fas), Fas ligand (Fas L), interferon-γ (IFN), insulin-like growth factor-I 
(IGF), progesterone (P4), P4 receptor (P4-R), mitogen-activated protein kinase (MAPK), phospholipase-A2 (PL-A2), arachi-
donic acid (AA), nuclear factor-κB (NFκB), jun-n-terminal kinase (JNK).
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apoptosis through the inactivation of Bcl-2 protein fol-
lowing activation of JNK in the luteal cells. In addition,
the engagement of TNF with TNFRI has been demon-
strated to activate sphingomyelin-ceramide pathways,
which results in apoptosis in some cell types [97]. The
multiple actions of TNF are due to the activation of com-
plex intracellular signaling pathways [98].
In contrast to TNFRI, information on the TNFRII in the
ovary is limited [99]. Recently, TNFRII was demonstrated
in the granulosa cells of porcine ovaries. Based on its pres-
ence, TNFRII was suggested to have a role in follicle atresia
[99]. Whether or not TNFRII has any significance in the
CL remains to be proven. In contrast to TNFR, numerous
studies have provided evidence that Fas mediates apop-
totic cell death through various intracellular signaling
pathways. Both soluble Fas L and anti-Fas monoclonal
antibody induced apoptosis in bovine luteal cells [64] and
rat thecal/interstitial cells [100] via activations of sphingo-
myelin-ceramide pathways. Moreover, it is thought that
the ratio of Bcl-2 to Bax expression is the critical determi-
nant of cell fate, such that elevated Bcl-2 favors extended
survival of cells, whereas increasing levels of Bax expres-
sion accelerate cell death [101,102]. Bcl-2 mRNA levels in
the human CL during the menstrual cycle were highest in
the midluteal phase and lowest in the regressing CL [103].
In contrast, bax mRNA levels were highest in the human
regressing CL [103]. These findings suggest that apoptosis
in the CL is regulated by a conserved pathway composed
of these central apoptosis-related genes. Recent study
demonstrated that the apoptosis-regulating factors Bcl-2,
Bax, caspase-3 and NFκB are present in human CL
throughout the estrous cycle [35]. The physiological
importance of TNFRII and intracellular mechanisms of
Fas-induced apoptosis in the CL are not completely
understood. Further studies are needed to clarify these
points.
Gestation period
The establishment of pregnancy is the result of a number
of interactions between the conceptus and mother. When
pregnancy is established, the CL is sustained and continu-
ously produces progesterone to maintain the pregnancy.
TNF and its receptor have been shown to be present in the
gravid uterus, placenta, oviduct and embryo [104]. In the
CL, it has been also demonstrated that high-affinity bind-
ing sites for TNF were present throughout the gestation
period, and that the concentrations of TNFR changed dur-
ing the gestational stages [28]. Furthermore, TNF mRNA
has been detected in the bovine [28] and porcine [29] CL
during the gestation period. These findings suggest that
locally produced TNF plays one or more roles in the
pregnant CL as an autocrine and/or paracrine mediator.
Since the concentration of TNFR as well as the abundance
of TNF mRNA were high in the CL of the late gestation
period [28], it is possible that TNF locally produced in the
CL contributes to luteal resorption during or following
parturition.
Specific binding sites for TNF were also found in the
bovine CL of the early and mid-gestational stages [28].
Furthermore, the affinity and the concentration of the
receptor in the CL of pregnancy are comparable with those
in the CL of the regressed stage [27]. Thus, TNF may also
act on CL function in the early and mid-gestational stages.
TNF stimulates PGE2 as well as PGF2α secretion by cul-
tured bovine luteal cells in a dose-dependent fashion [27].
Both luteal PGE2 and PGF2α in the CL are known to be
luteotropic agents, e.g., they stimulate progesterone pro-
duction by bovine CL in vitro [58,59]. Therefore, it could
be assumed that the luteal TNF contributes to the mainte-
nance of pregnancy by stimulating the production of
PGF2α and PGE2 by the CL of pregnancy, indirectly
resulting in an increase of progesterone output from the
CL of pregnancy. The CL of cows from day 200 of preg-
nancy secretes more PGE2 and PGF2α in vitro than those
of Day 14 of the estrous cycle [105]. Furthermore, proges-
terone production in vitro by CL from day 200 of preg-
nancy was increased by PGE2 but not by LH [106]. These
findings may support the above supposition that TNF
indirectly contributes to produce progesterone by stimu-
lation of luteal PGE2 in bovine CL during the gestation
period.
The physiological significance of Fas/Fas-L system in the
CL of pregnancy is still unknown. The only evidence for
the presence of Fas in the CL of pregnancy has been dem-
onstrated in mice [50]. Based on the characteristics of Fas/
Fas L system, it is possible that Fas-mediated apoptosis
contributes to the resorption of the pregnant CL. Further
studies are needed to understand the physiological mean-
ings of Fas/Fas L system in the pregnant CL.
Possible action of other TNF super family 
members on CL function
The TNF-SF is comprised of 18 members including TNF
and Fas L, and the TNFR-SF is comprised of 29 members
in human. Some members of the TNF-SF, such as EDA,
lymphotoxins (α and β), CD40, RANKL and TRAIL are
demonstrated their function in regulating immune sys-
tems in several species (reviewed in Ref. [107]). More
recently, DR5-like death receptors, which can bind TRAIL,
have been demonstrated in hen ovarian follicles [108].
Furthermore, TRAIL and its receptors have been detected
in the follicles of pigs [109]. These findings suggest that
TRAIL could regulate follicular development in mammals.
However, very little effort has been made to recognize the
physiological significance of these and other members of
the TNF-SF or TNFR-SF in luteal function. Consequently,
the roles of the other TNF-SF members in the CL will needReproductive Biology and Endocrinology 2003, 1 http://www.rbej.com/content/1/1/95
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to be delineated, so that we could promote a greater
understanding of cytokine-induced regulation of CL
function.
Conclusions
TNF plays multiple and important roles in CL function via
its specific receptors throughout the estrous cycle. TNF
seems to play a luteotropic role through the stimulation of
luteal PGF2α and PGE2 in early luteal phase. On the other
hand, luteolytic events, i.e., functional and structural lute-
olysis, are induced by this cytokine with other factors. IFN
appears to be an important modulator of luteolysis,
although the exact source and factors that contribute to
IFN production in the CL are unknown. A Fas L, a member
of TNF-SF, is recognized as an apoptotic agent. The apop-
totic function is exerted by binding its specific receptor
(Fas) to induce structural luteolysis. TNF and IFN appear
to play big roles in completing the structural luteolysis
mediated by Fas/Fas L system. Many factors, such as pro-
gesterone and IGF, are believed to inhibit Fas mediated
apoptosis in luteolysis in vitro.
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